Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY S LUY

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1932103272
CMS profile
268508
Location
RESTON, VA

General Payments · PY2018–2024

$3,072.10

  • Reported across 183 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$295.16

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $295.16 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $938.29 62
PY2019 $1,138.87 68
PY2020 $144.17 8
PY2021 $112.23 6
PY2022 $273.27 15
PY2023 $170.11 9
PY2024 $295.16 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $24.65 07/24/2024 Food and Beverage Undisputed 01/23/2026 1111639012 CMS
Amgen Inc. $21.25 11/06/2024 Food and Beverage Undisputed 01/23/2026 1111639014 CMS
AstraZeneca Pharmaceuticals LP $16.72 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105486131 CMS
AstraZeneca Pharmaceuticals LP $16.24 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105811297 CMS
Boston Scientific Corporation $20.51 12/19/2024 Food and Beverage Undisputed 01/23/2026 1092332883 CMS
CVRx, Inc. $23.49 09/16/2024 Food and Beverage Undisputed 01/23/2026 1133235180 CMS
Janssen Pharmaceuticals, Inc $18.68 08/05/2024 Food and Beverage Undisputed 01/23/2026 1078241625 CMS
Kiniksa Pharmaceuticals International, plc $20.12 02/07/2024 Food and Beverage Undisputed 01/23/2026 1154885240 CMS
Merck Sharp & Dohme LLC $19.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 1141898550 CMS
Novartis Pharmaceuticals Corporation $14.03 01/10/2024 Food and Beverage Undisputed 01/23/2026 1087055304 CMS
Novartis Pharmaceuticals Corporation $25.52 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087055328 CMS
Novartis Pharmaceuticals Corporation $20.52 10/16/2024 Food and Beverage Undisputed 01/23/2026 1087055334 CMS
PFIZER INC. $19.55 01/24/2024 Food and Beverage Undisputed 01/23/2026 1130984250 CMS
PFIZER INC. $16.36 02/27/2024 Food and Beverage Undisputed 01/23/2026 1131279527 CMS
PFIZER INC. $18.32 05/15/2024 Food and Beverage Undisputed 01/23/2026 1131512711 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.